2126
COM:JWTHERAPEUTICS
JW Therapeutics
- Stock
Last Close
1.38
22/11 07:59
Market Cap
755.92M
Beta: -
Volume Today
584.90K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Jan '18 | Mar '18 | Jun '18 | Jan '19 | Jun '19 | Dec '19 | Jun '20 | Dec '20 | Jun '21 | Dec '21 | Jun '22 | Dec '22 | Jun '23 | Dec '23 | Jun '24 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
net income | -68.15M - | -68.15M 0% | -68.15M 0% | -158.31M 132.29% | -357.87M 126.05% | -275.39M 23.05% | -650.03M 136.04% | -1.01B 55.96% | -280.69M 72.31% | -421.63M 50.21% | -429.25M 1.81% | -416.88M 2.88% | -380.42M 8.75% | -387.58M 1.88% | -240.27M 38.01% | |
depreciation and amortization | 1.28M - | 1.28M 0% | 1.28M 0% | 4.33M 238.68% | 6.81M 57.36% | 10.25M 50.59% | 10.50M 2.41% | 12.67M 20.69% | 15.39M 21.44% | 30.94M 101.08% | 41.37M 33.70% | 42.80M 3.46% | 49.52M 15.70% | 46.89M - | ||
deferred income tax | -75.82M - | 3.40M - | -19.47M - | |||||||||||||
stock based compensation | 3.86M - | 15.44M - | 57.47M 272.15% | 76.78M 33.60% | 63.98M 16.67% | 25.39M 60.32% | 48.97M 92.89% | 33.53M 31.53% | 31.95M 4.71% | 3.01M 90.58% | 18.56M 516.31% | |||||
change in working capital | -48.75K - | -48.75K 0% | -48.75K 0% | -4.72M 9,579.49% | -955K - | -28.78M - | -14.06M - | |||||||||
accounts receivables | -5.30M - | |||||||||||||||
inventory | -955K - | -28.78M - | -8.76M - | |||||||||||||
accounts payables | ||||||||||||||||
other working capital | ||||||||||||||||
other non cash items | 40.37M - | 40.37M 0% | 40.37M 0% | 107.62M 166.58% | 247.34M 129.83% | 164.50M 33.49% | 475.18M 188.87% | 771.15M 62.29% | -79.79M 110.35% | 114.01M 242.88% | -31.80M 127.89% | 208.08M 754.30% | 60.91M 70.73% | 384.57M 531.32% | -13.38M 103.48% | |
net cash provided by operating activities | -26.56M - | -26.56M 0% | -26.56M 0% | -47.23M 77.85% | -103.73M 119.62% | -85.20M 17.86% | -106.88M 25.45% | -154.13M 44.21% | -281.12M 82.39% | -280.08M 0.37% | -370.72M 32.36% | -166.00M 55.22% | -238.03M 43.39% | -188.20M - | ||
investments in property plant and equipment | -11.04M - | -11.04M 0% | -11.04M 0% | -28.52M 158.37% | -18.48M 35.20% | -83.47M 351.72% | -77.64M 6.98% | -46.60M 39.99% | -37.06M 20.45% | -36.02M 2.81% | -26.97M 25.12% | -49.90M 84.99% | -6.76M 86.45% | -2.87M - | ||
acquisitions net | ||||||||||||||||
purchases of investments | ||||||||||||||||
sales maturities of investments | ||||||||||||||||
other investing activites | 11.04M - | 11.04M 0% | 11.04M 0% | 28.52M 158.37% | -1.00M 103.52% | -14.60M 1,354.58% | 35.95M 346.15% | -3.62M 110.07% | -54.86M 1,415.81% | -9.19M 83.25% | -54.98M 498.57% | 7.78M 114.14% | 24.28M 212.22% | -10.07M - | ||
net cash used for investing activites | -11.04M - | -11.04M 0% | -11.04M 0% | -29.39M 166.27% | -19.48M 33.71% | -98.07M 403.40% | -41.69M 57.49% | -50.22M 20.44% | -91.92M 83.06% | -45.21M 50.82% | -81.96M 81.29% | -42.12M 48.60% | 17.52M 141.58% | -12.94M - | ||
debt repayment | -10.01M - | -17.62M 75.96% | -4.70M - | -5.24M - | -10.06M - | -35.55M - | -62.81M - | |||||||||
common stock issued | ||||||||||||||||
common stock repurchased | -683K - | -1K - | ||||||||||||||
dividends paid | ||||||||||||||||
other financing activites | -9.09M - | -9.09M 0% | -9.09M 0% | 10.01M 210.11% | 372.93M 3,624.24% | 58.74M 84.25% | 755.23M 1,185.67% | 2.11B 179.24% | -17.16M 100.81% | -7.54M 56.06% | -2.62M 65.25% | 125.03M 4,872.33% | 124.44M 0.47% | -5.76M - | ||
net cash used provided by financing activities | -9.09M - | -9.09M 0% | -9.09M 0% | -919.75K 89.89% | 355.31M 38,730.82% | 58.74M 83.47% | 750.53M 1,177.67% | 2.11B 180.99% | -22.40M 101.06% | -8.22M 63.29% | -12.68M 54.20% | 125.03M 1,086.07% | 88.90M 28.90% | 57.05M - | ||
effect of forex changes on cash | 74.80M - | 74.80M 0% | 74.80M 0% | 107.84M 44.17% | 7.42M 93.12% | 6.21M 16.37% | 3.38M 45.62% | -134.16M 4,073.84% | -28.82M 78.52% | -38.43M 33.36% | 150.69M 492.10% | -53.30M 135.37% | 21.17M 139.72% | 7.22M - | ||
net change in cash | 28.12M - | 28.12M 0% | 28.12M 0% | 30.30M 7.77% | 239.52M 690.48% | -118.32M 149.40% | 605.33M 611.61% | 1.77B 192.47% | -424.26M 123.96% | -371.94M 12.33% | -314.67M 15.40% | -136.40M 56.65% | -110.44M 19.03% | -136.88M - | ||
cash at beginning of period | 5.30M - | 5.30M 0% | 5.30M 0% | 33.42M 530.43% | 133.66M 300% | 373.19M 179.20% | 254.87M 31.71% | 860.20M 237.51% | 2.63B 205.81% | 2.21B 16.13% | 1.83B 16.86% | 1.52B 17.15% | 1.38B 8.97% | 1.27B 7.98% | 1.01B 20.97% | |
cash at end of period | 33.42M - | 33.42M 0% | 33.42M 0% | 63.72M 90.68% | 373.19M 485.70% | 254.87M 31.71% | 860.20M 237.51% | 2.63B 205.81% | 2.21B 16.13% | 1.83B 16.86% | 1.52B 17.15% | 1.38B 8.97% | 1.27B 7.98% | 1.27B 0% | 869.03M 31.73% | |
operating cash flow | -26.56M - | -26.56M 0% | -26.56M 0% | -47.23M 77.85% | -103.73M 119.62% | -85.20M 17.86% | -106.88M 25.45% | -154.13M 44.21% | -281.12M 82.39% | -280.08M 0.37% | -370.72M 32.36% | -166.00M 55.22% | -238.03M 43.39% | -188.20M - | ||
capital expenditure | -11.04M - | -11.04M 0% | -11.04M 0% | -28.52M 158.37% | -18.48M 35.20% | -83.47M 351.72% | -77.64M 6.98% | -46.60M 39.99% | -37.06M 20.45% | -36.02M 2.81% | -26.97M 25.12% | -49.90M 84.99% | -6.76M 86.45% | -2.87M - | ||
free cash flow | -37.59M - | -37.59M 0% | -37.59M 0% | -75.75M 101.49% | -122.20M 61.33% | -168.66M 38.02% | -184.52M 9.40% | -200.72M 8.78% | -318.18M 58.52% | -316.10M 0.65% | -397.69M 25.81% | -215.90M 45.71% | -244.79M 13.38% | -191.07M - |
All numbers in (except ratios and percentages)